TapImmune Inc.

TapImmune Inc.
Stock Exchange Other OTC
Market Cap
$111.85 M
Shares Outstanding
13.62 M
Public Float
12.12 M


5 West Forsyth Street
Jacksonville Florida 32202
United States
Employees -
Website http://www.tapimmune.com
Updated 09/14/2018
TapImmune, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL.


View All

Glynn Wilson
Peter L. Hoang
President, Chief Executive Officer & Director